Increased expression of cannabinoid receptor 1 in the nucleus accumbens core in a rat model with morphine withdrawal

Brain Research

Volumn 1531, Issue , 2013, Pages 102-112

  Yuan, Wei Xin ^a   Heng, Li Jun ^a,d   Ma, Jie ^a   Wang, Xing Qin ^a   Qu, Li Juan ^b   Duan, Li ^c   Kang, Jun Jun ^c   Chen, Liang Wei ^c   Gao, Guo Dong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

Cannabinoid receptor 1; Cannabinoid system; Conditioned place preference; Morphine withdrawal; Nucleus accumbens core; Rimonabant

Indexed keywords

CANNABINOID 1 RECEPTOR; MORPHINE; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG SEEKING BEHAVIOR; DRUG WITHDRAWAL; ELECTRON MICROSCOPY; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; MALE; MICROSCOPE; MORPHINE ADDICTION; NONHUMAN; NUCLEUS ACCUMBEN CORE; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALIA; RATTUS;

CANNABINOID RECEPTOR 1; CANNABINOID SYSTEM; CONDITIONED PLACE PREFERENCE; MORPHINE WITHDRAWAL; NUCLEUS ACCUMBENS CORE; RIMONABANT;

ANIMALS; DISEASE MODELS, ANIMAL; MALE; MORPHINE DEPENDENCE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; SUBSTANCE WITHDRAWAL SYNDROME; UP-REGULATION;

EID: 84883305501     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.07.047     Document Type: Article

References (64)

1. S.H. Ahmed, and G.F. Koob Cocaine- but not food-seeking behavior is reinstated by stress after extinction Psychopharmacology 132 1997 289 295
2. L. Alvarez-Jaimes, I. Polis, and L.H. Parsons Attenuation of cue-induced heroin-seeking behavior by cannabinoid CB1 antagonist infusions into the nucleus accumbens core and prefrontal cortex, but not basolateral amygdala Neuropsychopharmacology 33 2008 2483 2493
3. M.D. Black, R.J. Stevens, N. Rogacki, R.E. Featherstone, Y Senyah, O. Giardino, B. Borowsky, J. Stemmelin, C. Cohen, P. Pichat, M. Arad, S. Barak, A. De Levie, I. Weiner, G. Griebel, and G.B. Varty AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents Psychopharmacology 215 2011 149 163
4. G. Benard, F. Massa, N. Puente, J. Lourenco, L. Bellocchio, E. Soria-Gomez, I. Matias, A. Delamarre, M. Metna-Laurent, A. Cannich, E. Hebert-Chatelain, C. Mulle, S. Ortega-Gutierrez, M. Martin-Fontecha, M. Klugmann, S. Guggenhuber, B. Lutz, J. Gertsch, F. Chaouloff, M.L. Lopez-Rodriguez, P. Grandes, R. Rossignol, and G. Marsicano Mitochondrial CB(1) receptorsregulate neuronal energy metabolism Nat. Neurosci. 15 2012 558 564
5. R.M. Brown, and A.J. Lawrence Neurochemistry underlying relapse to opiate seeking behavior Neurochem Res. 34 2009 1876 1887
6. R.M. Carelli, and S. Ijames Nucleus accumbens cell firing during maintenance, extinction, and reinstatement of cocaine self-administration behavior in rats Brain Res. 866 2000 44 54
7. M.J. Christie Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction Br. J. Pharmacol. 154 2008 384 396
8. M.R. Darke S Mortality amongst illicit drug users: epidemiology causes and intervention. Vol. 2007 Cambridge University Press Cambridge
9. T.J. De Vries, and A.N.M. Schoffelmeer Cannabinoid CB1 receptors control conditioned drug seeking Trends Pharmacol. Sci. 26 8 2005 420 426
10. T.J. De Vries, A.N. Schoffelmeer, R. Binnekade, A.H. Mulder, and L.J. Vanderschuren Drug-induced reinstatement of heroin- and cocaine-seeking behavior following long-term extinction is associated with expression of behavioral sensitization Eur. J. Neurosci. 10 1998 3565 3571
11. D.G. Demuth, and A. Molleman Cannabinoid signalling Life Sci. 78 2006 549 563
12. V. Di Marzo, M. Bifulco, and L. De Petrocellis The endocannabinoid system and its therapeutic exploitation Nat. Rev. Drug. Dis. 3 2004 771 784
13. Q. Fang, F.Q. Li, Y.Q. Li, Y.X. Xue, Y.Y. He, J.F. Liu, L. Lu, and J.S. Wang Cannabinoid CB1 receptor antagonist rimonabant disrupts nicotine reward-associated memory in rats Pharmacol. Biochem. Behav. 99 2011 738 742
14. L. Fattore, M.S. Spano, G. Cossu, S. Deiana, and W. Fratta Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats Eur. J. Neurosci. 17 2003 1723 1726
15. L. Fattore, S. Spano, G. Cossu, S. Deiana, P. Fadda, and W. Fratta Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats Neuropharmacology 48 2005 1097 1104
16. L. Fattore, D. Vigano, P. Fadda, T. Rubino, W. Fratta, and D. Parolaro Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2 Eur. J. Neurosci. 25 2007 2191 2200
17. L. Fattore, M. Spano, V. Melis, P. Fadda, and W. Fratta Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats Br. J. Pharmacol. 163 2011 1550 1562
18. T.F. Freund, I. Katona, and D. Piomelli Role of endogenous cannabinoids in synaptic signaling Physiol. Rev. 83 2003 1017 1066
19. G. Gerdeman, and D.M. Lovinger CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum J. Neurophysiol. 85 2001 468 471
20. S. Gonzalez, J. Fernandez-Ruiz, V. Sparpaglione, D. Parolaro, and J.A. Ramos Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels Drug Alcohol Depend. 66 2002 77 84
21. A.F. Hoffman, and C.R. Lupica Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids J. Neurophysiol. 85 2001 72 83
22. S. Hosztafi Heroin addiction Acta Pharm. Hung. 81 2011 173 183
23. Z. Justinova, L.V. Panlilio, and S.R. Goldberg Drug addiction Curr. Top Behav. Neurosci. 1 2009 309 346
24. P.W. Kalivas, and K. McFarland Brain circuitry and the reinstatement of cocaine-seeking behavior Psychopharmacology (Berl.) 168 2003 44 56
25. M.R. Karlocai, K. Toth, M. Watanabe, C. Ledent, G. Juhasz, T.F. Freund, and Z. Magloczky Redistribution of CB1 cannabinoid receptors in the acute and chronic phases of pilocarpine-induced epilepsy PLoS One 6 2011 e27196
26. E. Kodas, C. Cohen, C. Louis, and G. Griebel Cortico-limbic circuitry for conditioned nicotine-seeking behavior in rats involves endocannabinoid signaling Psychopharmacology (Berl.) 194 2007 161 171
27. B. Le Foll, and S.R. Golsberg Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence J. Pharmacol. Exp. Ther. 312 2005 875 883
28. B. Lutz Molecular biology of cannabinoid receptors Prostaglandins Leukot. Essent. Fatty Acids 66 2002 123 142
29. K. Mackie Signaling via CNS cannabinoid receptors Mol. Cell Endocrinol. 286 2008 S60 S65
30. T. Maejima, T. Ohno-Shosaku, and M. Kano Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals Neurosci. Res. 40 2001 205 210
31. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
32. F. Matyas, Y. Yanovsky, K. Mackie, W. Kelsch, U. Misgeld, and T.F. Freund Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia Neuroscience 137 2006 337 361
33. K. McFarland, and A. Ettenberg Reinstatement of drug-seeking behavior produced by heroin-predictive environmental stimuli Psychopharmacology (Berl). 131 1997 86 92
34. K. McFarland, and P.W. Kalivas The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior J. Neurosci. 21 2001 8655 8663
35. W.M. Meil, and R.E. See Lesions of the basolateral amygdale abolish the ability of drug-associated cues to reinstate respond ing during withdrawal from self-administered cocaine Behav. Brain Res. 87 1997 139 148
36. T. Melis, S. Succu, F. Sanna, A. Boi, A. Argiolas, and M.R. Melis The cannabinoid antagonist SR 141716A (rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food Neurosci. Lett. 419 2007 231 235
37. V. Micale, L. Cristino, A. Tamburella, S. Petrosino, G.M. Leggio, F. Drago, and V. Di Marzo Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels Neuropsychopharmacology 34 2009 593 606
38. R. Morgenstern, T. Mende, R. Gold, P. Lemme, and W. Oelssner Drug-induced modulation of locomotor hyperactivity induced by picrotoxin in nucleus accumbens Pharmacol. Biochem. Behav. 21 1984 501 506
39. A. Peters, S.L. Palay, and H. deF. Webster The fine structure of the nervous system: neurons and their supporting cells Third ed. 1991 Oxford University Press New York 152 165
40. A.C. Porter, and C.C. Felder The endocannabinoid nervous system: unique opportunities for therapeutic intervention Pharmacol. Ther. 90 2001 45 60
41. J.M. Richard, A.M. Plawecki, and K.C. Berridge Nucleus accumbens GABAergic inhibition generates intense eating and fear that resists environmental retuning and needs no local dopamine Eur. J. Neurosci. 2013 1 14 10.1111/ejn.12194
42. D. Robbe, G. Alonso, F. Duchamp, J. Bockaert, and O.J. Manzoni Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens J. Neurosci. 21 2001 109 116
43. P. Roser, F.X. Vollenweider, and W. Kawohl Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists World J. Biol. Psychiatry 11 2010 208 219
44. T. Rubino, L. Tizzoni, D. Vigano, P. Massi, and D. Parolaro Modulation of rat brain cannabinoid receptors after chronic morphine treatment Neuroreport 8 1997 3219 3223
45. J.D. Salamone, P.J. McLaughlin, K. Sink, A. Makriyannisc, and L.A. Parker Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions Physiol. Behav. 91 2007 3838
46. A.N. Schoffelmeer, F. Hogenboom, G. Wardeh, and T.J. De Vries Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core Neuropharmacology 51 2006 773 781
47. D.W. Self, L.M. Genova, B.T. Hope, W.J. Barnhart, J.J. Spencer, and E.J. Nestler Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior J. Neurosci. 18 1998 1848 1859
48. Y. Shaham, D. Funk, S. Erb, T.J. Brown, C.D. Walker, and J. Stewart Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats J. Neurosci. 17 1997 2605 2614
49. U. Shalev, M. Morales, B. Hope, J. Yap, and Y. Shaham Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats Psychopharmacology (Berl.) 156 2001 98 107
50. L.P. Shearman, K.M. Rosko, R. Fleischer, J. Wang, S. Xu, X.S. Tong, and B.A. Rocha Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice Behav. Pharmacol. 14 2003 573 582
51. A.J. Scheen, N. Finer, P. Hollander, M.D. Jensen, and L.F. Van Gaal RIO-diabetes study group: efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study Lancet 368 2006 1660 1672
52. J. Shi, S.X. Li, X.L. Zhang, X. Wang, B. Le Foll, X.Y. Zhang, T.R. Kosten, and L. Lu Time-dependent neuroendocrine alterations and drug craving during the first month of abstinence in heroin addicts Am. J. Drug Alcohol Abuse 35 2009 267 272
53. P.E. Shreve, and N.J. Uretsky Role of quisqualic acid receptors in the hypermotility response produced by the injection of AMPA into the nucleus accumbens Pharmacol. Biochem. Behav. 30 1988 379 384
54. KS Sink, PJ McLaughlin, JA Wood, C. Brown, P. Fan, V.K. Vemuri, Y. Pang, T. Olzewska, G.A. Thakur, A. Makriyannis, L.A. Parker, and J.D. Salamone The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats Neuropsychopharmacology 33 2008 946 955
55. L.F. Van Gaal, A.M. Rissanen, A.J. Scheen, O. Ziegler, and S. Rössner for the RIO-Europe study group: effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study Lancet 365 2005 1389 1397
56. D. Vigano, M. Valenti, M.G. Cascio, V. Di Marzo, D. Parolaro, and T. Rubino Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine Eur. J. Neurosci. 20 2004 1849 1857
57. J. Wang, Z. Zhao, Q. Liang, X. Wang, C. Chang, and G. Gao The nucleus accumbens core has a more important role in resisting reactivation of extinguished conditioned place preference in morphine-addicted rats J. Int. Med. Res. 36 2008 673 681
58. W. Wang, D. Sun, B. Pan, C.J. Roberts, X. Sun, C.J. Hillard, and Q. Liu Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress Neuropsychopharmacology 35 2010 2249 2261
59. R.I. Wilson, and R.A. Nicoll Endocannabinoid signaling in the brain Science 296 2002 678 682
60. G. Wu, W. Huang, H. Zhang, Q. Li, J. Zhou, and H. Shu Inhibitory effects of processed Aconiti tuber on morphine-induced conditioned place preference in rats J. Ethnopharmacol. 136 2011 254 259
61. Z.X. Xi, J.G. Gilbert, X.Q. Peng, A.C. Pak, X. Li, and E.L. Gardner Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens J. Neurosci. 26 2006 8531 8536
62. D.S. Zahm The evolving theory of basal forebrain functional-anatomical 'macrosystems' Neurosci. Biobehav. Rev. 30 2006 148 172
63. D.S. Zahm Functional-anatomical implications of the nucleus accumbens core and shell subterritories Ann. N. Y. Acad. Sci. 877 1999 113 128
64. M.R. Zarrindast, M. Nouri, and S. Ahmadi Cannabinoid CB1 receptors of the dorsal hippocampus are important for induction of conditioned place preference (CPP) but do not change morphine CPP Brain Res. 1163 2007 130 137